Redcells Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -15.52%
- Profit Growth -1326.02%
- Ebitda -215.20%
- Net Worth -289.45%
- Total Assets -3.02%
About Redcells Diagnostics
Redcells Diagnostics Private Limited (RDPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 March 2015 (Nine years and 11 months 7 days old ). Its registered office is in Thane, Maharashtra.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Waghmare, Jainendra Pandey, and Umesh Mahajan serve as directors at the Company.
Company Details
-
LocationThane, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85191MH2015PTC262424
-
Company No.
262424
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Mar 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Redcells Diagnostics Private Limited offer?
Redcells Diagnostics Private Limited offers a wide range of products and services, including Test Kits, Hematology Analyzers, Cell Counter, Rapid Test Kit, Diagnostic Test Kit, Cholesterol Test Kit, Anti Cancer Medicines, Monoclonal Antibodies, Clinical Reagents, Diagnostic Reagents.
Who are the key members and board of directors at Redcells Diagnostics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jainendra Pandey
|
Director | 04-Mar-2015 | Current |
|
Sachin Waghmare
|
Director | 04-Mar-2015 | Current |
|
Umesh Mahajan
|
Director | 04-Mar-2015 | Current |
Financial Performance of Redcells Diagnostics.
Redcells Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.52% decrease. The company also saw a substantial fall in profitability, with a 1326.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 289.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Redcells Diagnostics?
Unlock access to Redcells Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Encore Biomedicals Private LimitedSachin Waghmare and Umesh Mahajan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Redcells Diagnostics?
Redcells Diagnostics has a workforce of 24 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Redcells Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redcells Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.